Chang Shen
No. 100 Haining Road
Shanghai, 200080, China
Shanghai, 200080, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
RIMTAC: A Novel Degrader Design Platform by Indirect VHL-Recruitment via RIPK1.
Journal: Journal of medicinal chemistry
Published: July 08, 2026
Substrate-Confined Lamb Waves Induced Thermal Field Modulation in Microscale Droplet.
Journal: Langmuir : the ACS journal of surfaces and colloids
Published: April 25, 2026
Parous female donor confers superior relapse protection in Haplo-PBSCT: A multicenter study of ATG/PTCy combination-based GVHD prophylaxis in AML/MDS.
Journal: Bone marrow transplantation
Published: October 15, 2025
Discovery of a first-in-class protein arginine methyltransferase 1 (PRMT1) degrader for nonenzymatic functions studies.
Journal: European journal of medicinal chemistry
Published: February 22, 2025
IPSS-M outperforms IPSS-R in prognostic stratification and guides effective interventions for very High-Risk myelodysplastic syndrome patients undergoing allogeneic hematopoietic stem cell transplantation.
Journal: Discover oncology
Published: January 31, 2025
Parous female donor is not inferior to the young male donor under the low-dose ATG/PTCy combination-based regimen for GVHD prophylaxis in haploidentical peripheral blood stem cell transplantation.
Journal: Leukemia research
Published: January 27, 2025
Epstein-Barr virus reactivation after haplo-peripheral blood stem cell transplantation in patients with hematological malignancies: immune reconstitution and influence on survival.
Journal: Therapeutic advances in hematology
Published: October 21, 2024
Improved survival in older patients with myeloid malignancies undergoing haploidentical peripheral blood stem cell transplantation with low-dose anti-thymocyte globin (ATG)/post-cyclophosphamide (PTCy)-based regimen for graft-versus-host disease prophylaxis.
Journal: Annals of hematology
Published: September 15, 2024
Low-dose anti-thymocyte globulin plus low-dose posttransplant cyclophosphamide-based regimen for prevention of graft-versus-host disease in haploidentical peripheral blood stem cell transplantation for pediatric patients with hematologic malignancies.
Journal: Annals of hematology
Published: April 23, 2024
Azacitidine combined with interferon-α for pre-emptive treatment of AML/MDS after allogeneic peripheral blood stem cell transplantation: A prospective phase II study.
Journal: British journal of haematology
Published: April 05, 2024
Last Updated: 09/26/2026